Long-term Extension Study of Ligelizumab in Food Allergy

Condition:   Food Allergy Interventions:   Drug: Ligelizumab 120 mg;   Drug: Ligelizumab 240 mg Sponsor:   Novartis Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials